Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia

NCT01566630 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Novartis terminated this study due to internal, strategic decisions.

Conditions

Pre-eclampsia

Interventions

DRUG: Placebo
DRUG: RLX030

Sponsor

Novartis Pharmaceuticals